Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Sep;93(3):448–451. doi: 10.1111/j.1365-2249.1993.tb08199.x

Expression of cytokine genes in human cardiac allografts: correlation of IL-6 and transforming growth factor-beta (TGF-beta) with histological rejection.

X M Zhao 1, W H Frist 1, T K Yeoh 1, G G Miller 1
PMCID: PMC1554893  PMID: 8370174

Abstract

Cytokines may play critical roles in allograft rejection. Currently, a clear pattern of cytokine production that correlates with rejection has not emerged. Our preliminary studies suggested a trend toward increased IL-6 and TGF-beta gene expression in cardiac allografts during rejection. We have extended these studies using reverse transcriptase/polymerase chain reaction (RT/PCR) to detect the expression of IL-6, TGF-beta, and T cell receptor beta chain constant region (TCR-beta) genes in 21 additional consecutive myocardial biopsies obtained from six heart transplant patients and from five pre-transplant donor hearts. Cytokine gene expression was compared with histological diagnosis of rejection. There was strong correlation between IL-6 as well as TGF-beta gene expression, and histological rejection (6/8 biopsies with versus 0/7 without rejection (P = 0.006) and 7/9 biopsies with versus 0/7 without rejection (P = 0.003) respectively). Neither IL-6 nor TGF-beta transcripts were detected in any pre-transplant donor heart. TCR-beta chain mRNA was found in all allograft biopsies regardless of the presence of rejection, but was absent in pre-transplant donor hearts. Our results indicate that expression of IL-6 and TGF-beta is highly correlated with allograft rejection and thus may play an important role in regulation of cardiac allograft rejection. T cell infiltration of allografted myocardium is invariably detected by PCR regardless of histological rejection. The long-term functional significance of these cells in transplanted hearts needs further investigation.

Full text

PDF
448

Images in this article

449Fig. 1
on p.449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990 Aug;4(11):2860–2867. [PubMed] [Google Scholar]
  2. Bauer J., Ganter U., Geiger T., Jacobshagen U., Hirano T., Matsuda T., Kishimoto T., Andus T., Acs G., Gerok W. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood. 1988 Oct;72(4):1134–1140. [PubMed] [Google Scholar]
  3. Bauer J., Herrmann F. Interleukin-6 in clinical medicine. Ann Hematol. 1991 Jun;62(6):203–210. doi: 10.1007/BF01729833. [DOI] [PubMed] [Google Scholar]
  4. Bishop G. A., Matsumoto Y., McCaughan G. W., Kenney J. S. Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1 beta, IL-6, IFN-gamma, and basic fibroblast growth factor. Transplant Proc. 1992 Oct;24(5):2310–2312. [PubMed] [Google Scholar]
  5. Brandes M. E., Allen J. B., Ogawa Y., Wahl S. M. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest. 1991 Mar;87(3):1108–1113. doi: 10.1172/JCI115073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caillat-Zucman S., Vanden Broecke C., Legendre C., Noel L. H., Kreis H., Bach J. F., Tovey M. G. Differential in situ expression of cytokine genes in human renal rejection. Transplant Proc. 1991 Feb;23(1 Pt 1):229–230. [PubMed] [Google Scholar]
  7. Chiang C. P., Nilsen-Hamilton M. Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-beta on the production of secreted proteins by murine 3T3 cells and human fibroblasts. J Biol Chem. 1986 Aug 15;261(23):10478–10481. [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Dallman M. J., Larsen C. P., Morris P. J. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med. 1991 Aug 1;174(2):493–496. doi: 10.1084/jem.174.2.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ford H. R., Hoffman R. A., Tweardy D. J., Kispert P., Wang S., Simmons R. L. Evidence that production of interleukin 6 within the rejecting allograft coincides with cytotoxic T lymphocyte development. Transplantation. 1991 Mar;51(3):656–661. doi: 10.1097/00007890-199103000-00022. [DOI] [PubMed] [Google Scholar]
  11. Ford H. R., Hoffman R. A., Wang S. A., Simmons R. L. Profile of cytokine production within the rejecting allograft. Transplant Proc. 1991 Feb;23(1 Pt 1):251–252. [PubMed] [Google Scholar]
  12. Hancock W. W., Tanaka K., Salem H. H., Tilney N. L., Atkins R. C., Kupiec-Weglinski J. W. TNF as a mediator of cardiac transplant rejection, including effects on the intragraft protein C/protein S/thrombomodulin pathway. Transplant Proc. 1991 Feb;23(1 Pt 1):235–237. [PubMed] [Google Scholar]
  13. Helfgott D. C., Tatter S. B., Santhanam U., Clarick R. H., Bhardwaj N., May L. T., Sehgal P. B. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol. 1989 Feb 1;142(3):948–953. [PubMed] [Google Scholar]
  14. Ignotz R. A., Endo T., Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987 May 15;262(14):6443–6446. [PubMed] [Google Scholar]
  15. Jordan S. C., Kondo T., Prehn J., Marchevsky A., Waters P. Cytokine gene activation in rat lung allografts: analysis by northern blotting. Transplant Proc. 1991 Feb;23(1 Pt 1):604–606. [PubMed] [Google Scholar]
  16. Kehrl J. H., Roberts A. B., Wakefield L. M., Jakowlew S., Sporn M. B., Fauci A. S. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol. 1986 Dec 15;137(12):3855–3860. [PubMed] [Google Scholar]
  17. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986 May 1;163(5):1037–1050. doi: 10.1084/jem.163.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kishimoto T. The biology of interleukin-6. Blood. 1989 Jul;74(1):1–10. [PubMed] [Google Scholar]
  19. Krams S. M., Falco D. A., Villanueva J. C., Rabkin J., Tomlanovich S. J., Vincenti F., Amend W. J., Melzer J., Garovoy M. R., Roberts J. P. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation. 1992 Jan;53(1):151–156. doi: 10.1097/00007890-199201000-00031. [DOI] [PubMed] [Google Scholar]
  20. Kuruvilla A. P., Shah R., Hochwald G. M., Liggitt H. D., Palladino M. A., Thorbecke G. J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918–2921. doi: 10.1073/pnas.88.7.2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Laiho M., Saksela O., Andreasen P. A., Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol. 1986 Dec;103(6 Pt 1):2403–2410. doi: 10.1083/jcb.103.6.2403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lindemann A., Ganser A., Hoelzer D., Mertelsmann R., Herrmann F. In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. Eur Cytokine Netw. 1991 May-Jun;2(3):173–176. [PubMed] [Google Scholar]
  23. Lipman M. L., Stevens A. C., Bleackley R. C., Helderman J. H., McCune T. R., Harmon W. E., Shapiro M. E., Rosen S., Strom T. B. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation. 1992 Jan;53(1):73–79. doi: 10.1097/00007890-199201000-00014. [DOI] [PubMed] [Google Scholar]
  24. Loppnow H., Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest. 1990 Mar;85(3):731–738. doi: 10.1172/JCI114498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Luger T. A., Schwarz T., Krutmann J., Kirnbauer R., Neuner P., Köck A., Urbanski A., Borth W., Schauer E. Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann N Y Acad Sci. 1989;557:405–414. doi: 10.1111/j.1749-6632.1989.tb24033.x. [DOI] [PubMed] [Google Scholar]
  26. Martinez O. M., Krams S. M., Sterneck M., Villanueva J. C., Falco D. A., Ferrell L. D., Lake J., Roberts J. P., Ascher N. L. Intragraft cytokine profile during human liver allograft rejection. Transplantation. 1992 Feb;53(2):449–456. doi: 10.1097/00007890-199202010-00035. [DOI] [PubMed] [Google Scholar]
  27. O'Connell P. J., Pacheco-Silva A., Nickerson P. W., Muggia R. A., Bastos M., Kelley V. R., Strom T. B. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol. 1993 Feb 1;150(3):1093–1104. [PubMed] [Google Scholar]
  28. Ranges G. E., Figari I. S., Espevik T., Palladino M. A., Jr Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med. 1987 Oct 1;166(4):991–998. doi: 10.1084/jem.166.4.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ray A., Sehgal P. B. Cytokines and their receptors: molecular mechanism of interleukin-6 gene repression by glucocorticoids. J Am Soc Nephrol. 1992 Jun;2(12 Suppl):S214–S221. doi: 10.1681/ASN.V212s214. [DOI] [PubMed] [Google Scholar]
  30. Rook A. H., Kehrl J. H., Wakefield L. M., Roberts A. B., Sporn M. B., Burlington D. B., Lane H. C., Fauci A. S. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986 May 15;136(10):3916–3920. [PubMed] [Google Scholar]
  31. Ruan X. M., Qiao J. H., Trento A., Czer L. S., Blanche C., Fishbein M. C. Cytokine expression and endothelial cell and lymphocyte activation in human cardiac allograft rejection: an immunohistochemical study of endomyocardial biopsy samples. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1110–1115. [PubMed] [Google Scholar]
  32. Ruscetti F. W., Palladino M. A. Transforming growth factor-beta and the immune system. Prog Growth Factor Res. 1991;3(2):159–175. doi: 10.1016/s0955-2235(05)80006-7. [DOI] [PubMed] [Google Scholar]
  33. Shenkin A., Fraser W. D., Series J., Winstanley F. P., McCartney A. C., Burns H. J., Van Damme J. The serum interleukin 6 response to elective surgery. Lymphokine Res. 1989 Summer;8(2):123–127. [PubMed] [Google Scholar]
  34. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989 Jan 15;142(2):549–553. [PubMed] [Google Scholar]
  35. Sun J., Matsumoto Y., McCaughan G. W., Gallagher N. D., Sheil A. G., Bishop G. A. Levels of cytokine expression in rat liver allograft rejection compared to allograft tolerance. Transplant Proc. 1992 Oct;24(5):2309–2309. [PubMed] [Google Scholar]
  36. Van Oers M. H., Van der Heyden A. A., Aarden L. A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988 Feb;71(2):314–319. [PMC free article] [PubMed] [Google Scholar]
  37. Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788–5792. doi: 10.1073/pnas.84.16.5788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wahl S. M., Hunt D. A., Wong H. L., Dougherty S., McCartney-Francis N., Wahl L. M., Ellingsworth L., Schmidt J. A., Hall G., Roberts A. B. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol. 1988 May 1;140(9):3026–3032. [PubMed] [Google Scholar]
  39. Wu C. J., Lovett M., Wong-Lee J., Moeller F., Kitamura M., Goralski T. J., Billingham M. E., Starnes V. A., Clayberger C. Cytokine gene expression in rejecting cardiac allografts. Transplantation. 1992 Aug;54(2):326–332. doi: 10.1097/00007890-199208000-00024. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES